亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Effect of Levetiracetam on Cognition in Patients With Alzheimer Disease With and Without Epileptiform Activity

左乙拉西坦 斯特罗普效应 临床痴呆评级 认知 癫痫 随机对照试验 医学 交叉研究 安慰剂 痴呆 心理学 听力学 物理疗法 精神科 疾病 内科学 认知障碍 替代医学 病理
作者
Keith Vossel,Kamalini G. Ranasinghe,Alexander J. Beagle,Alice La,Kasey Ah Pook,Madelyn Castro,Danielle Mizuiri,Susanne Honma,Nisha Venkateswaran,Mary Koestler,Wenbo Zhang,Lennart Mucke,Michael J. Howell,Katherine L. Possin,Joel H. Kramer,Adam L. Boxer,Bruce L. Miller,Srikantan S. Nagarajan,Heidi E. Kirsch
出处
期刊:JAMA Neurology [American Medical Association]
卷期号:78 (11): 1345-1345 被引量:184
标识
DOI:10.1001/jamaneurol.2021.3310
摘要

Network hyperexcitability may contribute to cognitive dysfunction in patients with Alzheimer disease (AD).To determine the ability of the antiseizure drug levetiracetam to improve cognition in persons with AD.The Levetiracetam for Alzheimer's Disease-Associated Network Hyperexcitability (LEV-AD) study was a phase 2a randomized double-blinded placebo-controlled crossover clinical trial of 34 adults with AD that was conducted at the University of California, San Francisco, and the University of Minnesota, Twin Cities, between October 16, 2014, and July 21, 2020. Participants were adults 80 years and younger who had a Mini-Mental State Examination score of 18 points or higher and/or a Clinical Dementia Rating score of less than 2 points. Screening included overnight video electroencephalography and a 1-hour resting magnetoencephalography examination.Group A received placebo twice daily for 4 weeks followed by a 4-week washout period, then oral levetiracetam, 125 mg, twice daily for 4 weeks. Group B received treatment using the reverse sequence.The primary outcome was the ability of levetiracetam treatment to improve executive function (measured by the National Institutes of Health Executive Abilities: Measures and Instruments for Neurobehavioral Evaluation and Research [NIH-EXAMINER] composite score). Secondary outcomes were cognition (measured by the Stroop Color and Word Test [Stroop] interference naming subscale and the Alzheimer's Disease Assessment Scale-Cognitive Subscale) and disability. Exploratory outcomes included performance on a virtual route learning test and scores on cognitive and functional tests among participants with epileptiform activity.Of 54 adults assessed for eligibility, 11 did not meet study criteria, and 9 declined to participate. A total of 34 adults (21 women [61.8%]; mean [SD] age, 62.3 [7.7] years) with AD were enrolled and randomized (17 participants to group A and 17 participants to group B). Thirteen participants (38.2%) were categorized as having epileptiform activity. In total, 28 participants (82.4%) completed the study, 10 of whom (35.7%) had epileptiform activity. Overall, treatment with levetiracetam did not change NIH-EXAMINER composite scores (mean difference vs placebo, 0.07 points; 95% CI, -0.18 to 0.32 points; P = .55) or secondary measures. However, among participants with epileptiform activity, levetiracetam treatment improved performance on the Stroop interference naming subscale (net improvement vs placebo, 7.4 points; 95% CI, 0.2-14.7 points; P = .046) and the virtual route learning test (t = 2.36; Cohen f2 = 0.11; P = .02). There were no treatment discontinuations because of adverse events.In this randomized clinical trial, levetiracetam was well tolerated and, although it did not improve the primary outcome, in prespecified analysis, levetiracetam improved performance on spatial memory and executive function tasks in patients with AD and epileptiform activity. These exploratory findings warrant further assessment of antiseizure approaches in AD.ClinicalTrials.gov Identifier: NCT02002819.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
俊逸沛菡完成签到 ,获得积分10
23秒前
25秒前
可靠雨文发布了新的文献求助10
29秒前
噼里啪啦完成签到 ,获得积分10
32秒前
科研通AI2S应助科研通管家采纳,获得10
36秒前
Jasper应助科研通管家采纳,获得10
36秒前
江小鱼在查文献完成签到,获得积分10
41秒前
chen发布了新的文献求助10
42秒前
123完成签到,获得积分10
45秒前
fx完成签到 ,获得积分10
46秒前
chen完成签到,获得积分10
1分钟前
ZYSNNNN完成签到,获得积分10
1分钟前
iiii完成签到,获得积分20
1分钟前
zhuanghj5完成签到,获得积分10
1分钟前
吴玉婷关注了科研通微信公众号
1分钟前
1分钟前
明昼完成签到,获得积分10
1分钟前
肉丸完成签到 ,获得积分10
1分钟前
安安爱阎魔完成签到,获得积分10
1分钟前
吴玉婷发布了新的文献求助30
1分钟前
绝世冰淇淋完成签到 ,获得积分10
2分钟前
2分钟前
chi完成签到 ,获得积分10
2分钟前
我是老大应助wuran采纳,获得10
2分钟前
核桃发布了新的文献求助10
2分钟前
别来无恙完成签到 ,获得积分10
2分钟前
2分钟前
吴玉婷完成签到,获得积分20
2分钟前
博慧发布了新的文献求助10
2分钟前
tianya完成签到,获得积分10
2分钟前
能干的台灯完成签到,获得积分10
2分钟前
2分钟前
Lucas应助科研通管家采纳,获得10
2分钟前
ly完成签到,获得积分10
2分钟前
2分钟前
在水一方应助和和和采纳,获得10
2分钟前
wuran发布了新的文献求助10
2分钟前
AiQi完成签到 ,获得积分10
3分钟前
3分钟前
博慧完成签到,获得积分10
3分钟前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3990015
求助须知:如何正确求助?哪些是违规求助? 3532077
关于积分的说明 11256227
捐赠科研通 3270933
什么是DOI,文献DOI怎么找? 1805139
邀请新用户注册赠送积分活动 882270
科研通“疑难数据库(出版商)”最低求助积分说明 809228